Some patients take specific medications to manage high blood pressure. These drugs are often used alongside clot-busting treatments to treat serious medical issues. However, combining these two types of medicine can sometimes lead to a dangerous and rapid swelling of the face, lips, or throat.
Research shows that patients taking certain blood pressure medications have a much higher chance of experiencing this severe swelling when they receive clot-busting drugs. While the overall death rates were similar between patients who took only one type of medicine and those who took both, the risk of severe swelling was much higher in the combination group.
Doctors should carefully check a patient's medical history before starting treatment. It is important to know if a patient is already taking blood pressure medication. This helps doctors monitor for any signs of swelling and choose the safest treatment plan for the patient.
Common questions
What is angioedema and is it serious?
Angioedema is a condition that causes swelling. In this study, it was identified as a serious adverse event. The research looked at how the combination of thrombolytic therapy and RAAS-i medications, such as ACE inhibitors, might increase the risk of this condition occurring in patients.
Does the combination of these drugs affect mortality?
The study found that mortality rates were comparable between patients receiving thrombolytic monotherapy and those receiving the combination of thrombolytic therapy and RAAS-i. While the combination showed a link to increased angioedema risk, it did not show a difference in mortality rates.
Which specific medications were involved in the study?
The study looked at thrombolytic therapies, specifically alteplase and tenecteplase. It also examined these in combination with renin-angiotensin-aldosterone system inhibitors (RAAS-i), which include ACE inhibitors. Both alteplase and tenecteplase showed signals for increased risk when used in these contexts.
